Background
Sarcopenia is a growing concern owing to an aging global population. Older people with depression are at risk for sarcopenia and vice versa. Although physical exercise is key in preventing and managing sarcopenia, virtual reality (VR)-based exercises have emerged as an engaging alternative that may also alleviate depressive symptoms and enhance quality of life in older adults. However, the effects of VR exercise on depression in individuals with sarcopenia who are at higher risk of both physical decline and psychological distress remain underexplored.
Objective
This study aimed to explore the benefits of home-based VR aerobic exercise combined with resistance training for reversing sarcopenia and depression in community-dwelling older adults with sarcopenia.
Methods
This blinded randomized controlled trial enrolled 46 community-dwelling older adults with sarcopenia (37 females and 9 males); they were categorized into the home-based VR (n = 23) group receiving non-immersive VR aerobic exercise combined with a resistance program and the control group (CG) receiving self-care education (CG; n = 23). The VR program combined aerobic and resistance exercises, performed three times weekly for 12 weeks. Sarcopenia risk indicators, including gait speed, handgrip strength, skeletal muscle mass index (SMI), and depression scores, were examined before and after the intervention. A two-way mixed repeated-measures analysis of variance was performed.
Results
The VR group showed significant improvements in depressive symptoms (F(1,44)=51.80, p< 0.001), SMI (F(1,44) =28.07, p< 0.001), handgrip strength (F(1,44) = 66.74, p< 0.001, np2=0.599), and gait speed (F(1,44)=0.67, p< 0.001), whereas the CG showed reduced SMI (F(1,44) =7.55, p= 0.009) and handgrip strength F(1,44) =14.99, p< 0.001).
Conclusions
Home-based VR aerobic exercise combined with resistance training improves muscle mass, muscle strength, and physical performance and reduces depression in older adults with sarcopenia. Thus, it may be applied to effectively prevent or reverse sarcopenia and decrease depression among older adults.
Trial registration
The Thai Clinical Trials Registry is TCTR20231005004.
扫码关注我们
求助内容:
应助结果提醒方式:
